Ovulation disorders are medical conditions in which the ovaries do not release an egg normally during the menstrual cycle. They account for approximately 25 to 30 percent of all female infertility cases and are the single most common cause of infertility in women. Types of ovulation disorders include PCOS, hypothalamic dysfunction, hyperprolactinemia, premature ovarian insufficiency, thyroid dysfunction affecting ovulation, and luteal phase defect. Most ovulation disorders are highly responsive to treatment, making them among the most successfully managed causes of infertility.

Ovulation disorders symptoms include irregular periods (cycles shorter than 21 days or longer than 35 days), infrequent periods (fewer than 8 cycles per year), complete absence of periods (amenorrhoea), difficulty conceiving despite regular intercourse, excessive facial or body hair (hirsutism), acne and oily skin, unexplained weight gain, and milky nipple discharge (galactorrhoea, specific to hyperprolactinemia). However, some women with ovulation disorders have no outward symptoms whatsoever. A condition called silent anovulation — where a cycle appears normal but no egg is released — is well recognised. Any woman who has been trying to conceive for 12 months without success should have an ovulation assessment even if periods appear regular.

Ovulation disorder treatment is selected based on the specific type of ovulation disorder identified at diagnosis. For PCOS, first-line treatment is ovulation induction with Letrozole or Clomiphene citrate, combined with Metformin for insulin resistance. For hypothalamic dysfunction, weight restoration and lifestyle correction often restore natural ovulation, with gonadotropin injections where needed. For hyperprolactinemia, Bromocriptine or Cabergoline reduces prolactin and restores ovulation in most patients. For thyroid-related ovulation disorders, normalising thyroid hormones restores the cycle. For luteal phase defect, progesterone supplementation after ovulation supports the endometrium. For premature ovarian insufficiency, IVF with donor eggs is the primary fertility option. All ovulation induction cycles at Javitri Hospital are monitored with serial ultrasound scans.

PCOS (polycystic ovary syndrome) is the most common type of ovulation disorder, affecting approximately 1 in 10 women of reproductive age. In PCOS, elevated insulin levels cause the ovaries to produce excess androgens (male hormones). This hormonal imbalance disrupts the normal signals that trigger follicle maturation and egg release. As a result, multiple small follicles develop on the ovaries but none matures fully to release an egg. This pattern, called oligo-ovulation or anovulation, is the main cause of infertility in PCOS. Ovulation disorder treatment for PCOS includes Metformin (for insulin resistance), Letrozole or Clomiphene for ovulation induction, and laparoscopic ovarian drilling for medication-resistant cases.

Javitri Hospital offers the most complete ovulation disorder treatment programme in Lucknow, covering all types of ovulation disorders including PCOS, hypothalamic dysfunction, hyperprolactinemia, premature ovarian insufficiency, thyroid-related anovulation, and luteal phase defect. Ovulation disorders symptoms are investigated with a full hormonal panel and follicle tracking ultrasound before any treatment begins. All ovulation induction cycles are closely monitored for safety and effectiveness. Furthermore, Dr. Rajul Tyagi’s 30 plus years of experience with international training at Cleveland Clinic USA and University Hospital Brussels Belgium, together with Dr. Archana Rastogi and Dr. Shivani Agarwal, ensures that every case of ovulation disorder receives precise, targeted, and compassionate care.

Ovulation disorders are diagnosed using a structured investigation panel at Javitri Hospital. Hormonal blood tests measure FSH, LH, AMH, prolactin, TSH, free T4, testosterone, DHEAS, and day-21 progesterone, identifying the specific hormonal abnormality. Follicle tracking ultrasound assesses follicle development through the cycle and confirms whether an egg is actually released. Pelvic ultrasound evaluates ovarian morphology for polycystic appearance and measures antral follicle count. This combination of hormonal and imaging findings enables WHO classification of the ovulation disorder type, directing targeted treatment.

Yes, in many cases. Most ovulation disorders are among the most successfully treated causes of female infertility. With appropriate ovulation disorder treatment, a large proportion of women with PCOS, hypothalamic dysfunction, or hyperprolactinemia achieve successful ovulation and go on to conceive naturally or with IUI (intrauterine insemination). If ovulation is restored but pregnancy does not follow after several cycles, IVF provides the next step. Even women with premature ovarian insufficiency can achieve pregnancy through IVF with donor eggs. The prognosis depends on the type of ovulation disorder, age, and other factors assessed at your consultation.

Yes. Ovulation disorders symptoms often overlap with other conditions, which is why accurate diagnosis is important. Irregular periods may be attributed to stress or lifestyle without investigating ovulation. Hirsutism and acne can be treated as purely cosmetic issues without identifying underlying PCOS. Absent periods may be attributed to low body weight alone without checking for premature ovarian insufficiency. Galactorrhoea (nipple discharge) can be missed as a sign of hyperprolactinemia. Furthermore, as noted, some women with ovulation disorders have no recognisable symptoms at all. A structured hormonal and ultrasound assessment is the only reliable way to confirm whether ovulation is occurring normally.

Ovulation induction is the use of medication to stimulate the ovaries to develop and release an egg in women who are not ovulating normally. It is the primary ovulation disorder treatment for PCOS, hypothalamic dysfunction, and similar conditions. At Javitri Hospital, all ovulation induction cycles are carefully monitored with serial follicle tracking scans to confirm follicle growth, time the trigger injection precisely, and prevent ovarian hyperstimulation syndrome (OHSS). Medication options include Letrozole (first-line for PCOS), Clomiphene citrate, and gonadotropin injections (FSH and LH) for cases resistant to oral medication.

The main types of ovulation disorders classified by the WHO are: WHO Class I (hypothalamic dysfunction) caused by low body weight, excessive exercise, or stress suppressing GnRH release; WHO Class II (PCOS), the most common type, where elevated insulin and androgens prevent follicle maturation; WHO Class III (premature ovarian insufficiency), where the ovaries stop functioning normally before age 40; and WHO Class IV (hyperprolactinemia), where elevated prolactin suppresses ovulation. Additionally, thyroid disorders (both hypothyroidism and hyperthyroidism) disrupt the hormonal axis controlling ovulation, and luteal phase defect involves insufficient progesterone after ovulation to support implantation.